Protexia
QOPK 4439
Phase 1 mab completed
Quick answer
Protexia for Intervention for Nerve Agent Exposure is a Phase 1 program (mab) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- UNITED THERAPEUTICS Corp
- Indication
- Intervention for Nerve Agent Exposure
- Phase
- Phase 1
- Modality
- mab
- Status
- completed